U.S. markets closed
  • S&P Futures

    4,549.25
    +4.75 (+0.10%)
     
  • Dow Futures

    35,422.00
    +33.00 (+0.09%)
     
  • Nasdaq Futures

    15,605.25
    +18.00 (+0.12%)
     
  • Russell 2000 Futures

    2,254.20
    +4.70 (+0.21%)
     
  • Crude Oil

    80.76
    -1.90 (-2.30%)
     
  • Gold

    1,804.10
    +5.30 (+0.29%)
     
  • Silver

    24.17
    -0.03 (-0.11%)
     
  • EUR/USD

    1.1612
    +0.0005 (+0.05%)
     
  • 10-Yr Bond

    1.5290
    -0.0900 (-5.56%)
     
  • Vix

    16.98
    +1.00 (+6.26%)
     
  • GBP/USD

    1.3742
    -0.0000 (-0.00%)
     
  • USD/JPY

    113.5800
    -0.2300 (-0.20%)
     
  • BTC-USD

    58,891.07
    -1,661.35 (-2.74%)
     
  • CMC Crypto 200

    1,411.72
    -62.61 (-4.25%)
     
  • FTSE 100

    7,253.27
    -24.35 (-0.33%)
     
  • Nikkei 225

    28,825.62
    -272.62 (-0.94%)
     

The FDA Is Likely To Sign Off On Covid Boosters — With Some Caveats For Pfizer, Moderna

·3 min read
The FDA Is Likely To Sign Off On Covid Boosters — With Some Caveats For Pfizer, Moderna
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Booster shots could expand the opportunity for Covid vaccine stocks like Pfizer and Moderna by $3 billion to $4 billion in the U.S. alone.